![James Kinley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Kinley
Director of Finance/CFO at
GREY MATTERS HEALTH INC.
Net worth: 99 006 $ as of 30/06/2026
Profile
James F.
Kinley is Chief Financial Officer & Director at Medicure, Inc. since 2026, Independent Director at Waverley Pharma, Inc. since 2024, Chief Financial Officer at Cytophage Technologies Ltd. since 2026, Chief Financial Officer & Secretary at Grey Matters Health, Inc. since 2022, and Chief Financial Officer at Algernon Neuroscience, Inc. Former roles include Principal at Ernst & Young LLP, Chief Financial Officer at Medicure, Inc. from 2011 to 2021, Manager at Manitoba Telecom Services, Inc., and Chief Financial Officer at Luminor Medical Technologies, Inc. from 2011 to 2016.
Education includes undergraduate studies at Asper School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 05/06/2026 | 2,11,492 ( 3.9% ) | 66 197 $ | 30/06/2026 | |
MEDICURE INC. 0.45% | 02/04/2026 | 47,100 ( 0.45% ) | 31 793 $ | 30/06/2026 |
| 05/05/2025 | 56,500 ( 0.1% ) | 1 017 $ | 30/06/2026 |
James Kinley active positions
| Companies | Position | Start |
|---|---|---|
| GREY MATTERS HEALTH INC. | Director of Finance/CFO | 01/12/2021 |
| MEDICURE INC. | Director of Finance/CFO | 24/07/2026 |
| WAVERLEY PHARMA INC. | Director/Board Member | 20/06/2024 |
| CYTOPHAGE TECHNOLOGIES LTD. | Director of Finance/CFO | 20/01/2026 |
Algernon Neuroscience, Inc. | Director of Finance/CFO | - |
Former positions of James Kinley
| Companies | Position | End |
|---|---|---|
| MEDICURE INC. | Director of Finance/CFO | 15/05/2021 |
Luminor Medical Technologies, Inc.
 Luminor Medical Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research and development services | Director of Finance/CFO | 18/01/2016 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Corporate Officer/Principal | - |
| BELL MTS | Corporate Officer/Principal | - |
Training of James Kinley
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
41
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Medicure, Inc.
 Medicure, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research, development and commercialization & marketing of human therapeutics products | Health Technology |
Manitoba Telecom Services, Inc.
 Manitoba Telecom Services, Inc. Wireless TelecommunicationsCommunications Provides telecommunications services | Communications |
Luminor Medical Technologies, Inc.
Luminor Medical Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research and development services | Commercial Services |
Asper School of Business
 Asper School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Algernon Pharmaceuticals, Inc.
 Algernon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage, drug development and repurposing company | Health Technology |
Waverley Pharma, Inc.
 Waverley Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Algernon Neuroscience, Inc. | |
Cytophage Technologies Ltd.
 Cytophage Technologies Ltd. Financial ConglomeratesFinance Produces bacteriophages for bacterial infections and diseases | Finance |
- Stock Market
- Insiders
- James Kinley
